IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NLS Pharmaceutics LTD

Q2 2025 vs Q3 2025

Comparing institutional holders between quarters

Quarters

Q3 2025Q2 2025Q2 2024Q1 2024Q4 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
CoreCap Advisors, LLC
UNCHANGED
Shares36 from 36
Change0 (0%)
Value$66 (-$38)
Filed 2025-10-22
Status
CoreCap Advisors, LLC
UNCHANGED363600%$104$66-$382025-10-22
Showing 1 of 1 institutions